Testing effectiveness (Phase 2)Study completedNCT00217503
What this trial is testing
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
Who this might be right for
Lymphoma
National Cancer Institute (NCI) 15